<DOC>
	<DOCNO>NCT02636218</DOCNO>
	<brief_summary>Subarachnoid hemorrhage ( SAH ) bleed brain result rupture aneurysm devastate type stroke . Many patient undergo emergent neurosurgery repair aneurysm remove bleed suffer complication subsequent hospital stay , frequent morbid delay cerebral ischemia ( DCI ) small stroke result impaired blood flow certain vital brain center . This occur change brain 's blood vessel occur bleed . The artery become narrow ( spasm ) small clot form within vasculature disrupts normal blood flow . Patients leave profound neurologic deficit secondary complication . Anesthesiologists , neurosurgeon , intensivists need way protect brain vulnerable period follow aneurysm repair . One drug may provide protection ketamine , compound frequently use operating room intensive care unit provide anesthesia analgesia . Ketamine work block glutamate receptor ion channel play pivotal role promote brain cell death stroke flood brain much calcium dangerous chemical . This project design test efficacy ketamine protect brain follow aneurysm repair use control infusion drug intensive care unit ( ICU ) patient return operation .</brief_summary>
	<brief_title>Ketamine Infusion Neurologic Deficit</brief_title>
	<detailed_description>Aneurysmal subarachnoid hemorrhage ( aSAH ) devastate type stroke , significant long-term morbidity patient survive initial bleed . The frequent morbid complication delay cerebral ischemia ( DCI ) result angiographic vasospasm artery circle Willis . At present , protective therapy aim neuronal preservation period ischemia . The standard medical care primarily maintain intravascular volume status improve cerebral perfusion arterial narrowing , calcium channel blocker smooth muscle relaxation arterial wall . Experimental clinical data suggest primary mechanism neuronal injury ischemia excitotoxicity , glutamate-induced cell death result overstimulation ionotropic N-methyl-D-aspartate ( NMDA ) receptor resultant excessive calcium influx . Ketamine dissociative anesthetic mechanism action non-competitive antagonism NMDA receptor , routinely use operating room intensive care unit analgesic anesthetic . In addition anesthetic property , ketamine also anti-inflammatory agent sympathomimetic , maintain sedation without adverse effect hemodynamic instability . Identification neuroprotective entity DCI follow SAH would vastly improve quality life shorten hospital stay patient rupture intracerebral aneurysm . It critical identify agent patient survive injury , spend short time ICU , return work maintain relationship .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 . Male female 18 70 year old . 2 . World Federation Neurological Surgeons ( WFNS ) grade 2 4 , obtain resuscitation prior dose . 3 . SAH admission cranial compute tomography ( CT ) scan ( diffuse clot present hemisphere , thin thick [ &gt; 4 mm ] , local thick SAH ( &gt; 4 mm ) . 4 . Ruptured saccular aneurysm , confirm catheter angiography ( CA ) CT angiography ( CTA ) treat neurosurgical clipping endovascular coiling . 5 . External ventricular drain place part routine care . 6 . Able dose within 4 hour new neurologic deficit . 7 . Historical modify Rankin score 0 1 . 8 . Hemodynamically stable resuscitation ( systolic blood pressure &gt; 100 mm Hg ) 9 . Haemoglobin &gt; 85 g/L , platelet &gt; 125,000 cells/mm3 10 . Informed consent . 11 . New neurologic deficit present previously , identify 1 ) decrease 2 point modify Glasgow coma scale ( mGCS ) 2 ) increase 2 point National Institute Health Stroke Scale ( NIHSS ) . i.e. , CODE VASOSPASM initiate ICU . 1 . Subarachnoid hemorrhage due cause saccular aneurysm ( e.g. , trauma rupture fusiform infective aneurysm ) . 2 . WFNS Grade 1 5 assessed completion aneurysm repair . 3 . Increased intracranial pressure ( ICP ) &gt; 30 mm Hg sedate patient last &gt; 4 hour anytime since admission . 4 . Intraventricular intracerebral hemorrhage absence SAH local , thin SAH . 5 . Angiographic vasospasm prior aneurysm repair procedure , document catheter angiogram CT angiogram . 6 . Major complication aneurysm repair , limited , massive intraoperative hemorrhage , brain swelling , arterial occlusion , inability secure rupture aneurysm . 7 . Aneurysm repair require flow divert stent stentassisted coil dual antiplatelet therapy . 8 . Hemodynamically unstable prior administration study drug ( i.e. , SBP &lt; 90 mm Hg , require &gt; 6 L colloid crystalloid fluid resuscitation ) . 9 . Cardiopulmonary resuscitation require follow SAH . 10 . Female patient positive pregnancy test ( blood urine ) screening . 11 . History within past 6 month and/or physical find admission decompensated heart failure ( New York Heart Association [ NYHA ] Class III IV heart failure require hospitalization ) . 12 . Acute myocardial infarction within 3 month prior administration study drug . 13 . Symptoms electrocardiogram ( ECG ) base sign acute myocardial infarction unstable angina pectoris admission . 14 . Electrocardiogram evidence and/or physical finding compatible second third degree heart block cardiac arrhythmia associate hemodynamic instability . 15 . Echocardiogram , perform part standardofcare treatment , reveal leave ventricular ejection fraction ( LVEF ) &lt; 40 % . 16 . Severe unstable concomitant condition disease ( e.g. , know significant neurologic deficit , cancer , hematologic , coronary disease ) , chronic condition ( e.g. , psychiatric disorder ) , opinion Investigator , may increase risk associate study participation study drug administration , may interfere interpretation study result . 17 . Patients receive investigational product participate another interventional clinical study within 30 day prior randomization . 18 . Kidney disease define plasma creatinine â‰¥2.5 mg/dl ( 221 umol/l ) ; liver disease define total bilirubin &gt; 3 mg/dl ( 51.3 mmol/l ) ; and/or know diagnosis clinical suspicion liver cirrhosis . 19 . Known hypersensitivity contraindication ketamine per product monograph .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ketamine</keyword>
</DOC>